Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension.
Abman SH, Kinsella JP, Rosenzweig EB, Krishnan U, Kulik T, Mullen M, Wessel DL, Steinhorn R, Adatia I, Hanna B, Feinstein J, Fineman J, Raj U, Humpl T; Pediatric Pulmonary Hypertension Network (PPHNet).
Abman SH, et al. Among authors: wessel dl.
Am J Respir Crit Care Med. 2013 Mar 15;187(6):572-5. doi: 10.1164/rccm.201210-1928PP. Epub 2012 Dec 6.
Am J Respir Crit Care Med. 2013.
PMID: 23220921